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Abstract
Causal inference on multiple non-independent outcomes raises serious chal-
lenges, because multivariate techniques that properly account for the outcome’s
dependence structure need to be considered. We focus on the case of binary
outcomes framing our discussion in the potential outcome approach to causal
inference. We define causal effects of treatment on joint outcomes introduc-
ing the notion of product outcomes. We also discuss a decomposition of the
causal effect on product outcomes into marginal and joint causal effects, which
respectively provide information on treatment effect on the marginal (product)
structure of the product outcomes and on the outcomes’ dependence structure.
We propose a log-mean linear regression approach for modeling the distribution
of the potential outcomes, which is particularly appealing because all the causal
estimands of interest and the decomposition into marginal and joint causal ef-
fects can be easily derived by model parameters. The method is illustrated in
two randomized experiments concerning (i) the effect of the administration of
oral pre-surgery morphine on pain intensity after surgery; and (ii) the effect of
honey on nocturnal cough and sleep difficulty associated with childhood upper
1
respiratory tract infections.
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1 Introduction
Causal studies involving multivariate outcome variables are increasingly widespread
in real-world applications: intervention studies in many fields routinely collect infor-
mation on multiple outcomes. Recently, a strand of the causal inference literature has
been working on using multiple outcomes, possible coupled with conditional indepen-
dence assumptions, to address identification problems in causal studies with interme-
diate variables (Mattei et al., 2013; Mealli and Pacini, 2013; Mercatanti et al., 2015;
Mealli et al., 2016). In these studies focus is on causal effects on a single response
variable, which is viewed as the outcome of main interest, and additional outcomes
are used as auxiliary variables for inferential purposes.
In this paper we consider a different type of studies, where focus is on causal ef-
fects on a multivariate response variable, and thus the whole vector of outcomes is the
response variable of main interest. Assessing causal effects on multivariate outcomes
presents unique challenges, because causal effects on joint sets of endpoint outcomes
need to be properly defined, and multivariate inferential methods for identifying and
estimating those causal estimands that also properly account for the outcomes’ de-
pendence structure need to be developed.
The existing causal inference literature has rarely focused on assessing causal ef-
fects on multivariate response variables. Some exceptions include Jo and Muthe´n
(2001), who conduct a joint analysis with two outcomes in the context of a random-
ized trial with noncompliance; Herna´n et al. (2002), who focus on estimating causal
effects of a time-varying treatment on the mean of a repeated measures outcome us-
ing a marginal structural model; Flanders and Klein (2015), who propose a general
definition of causal effects, showing how it can be applied in the presence of multivari-
ate outcomes to define causal effects for specific sub-populations of units or vector of
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causal effects; and Li and Peng (2017), who establish finite population central limit
theorems in completely randomized experiments where the response variable may be
multivariate and causal estimands of interest are defined as linear combinations of
the potential outcomes.
We focus on assessing causal effects of a treatment on multiple binary outcomes.
The binary nature of the outcomes raises further challenges. When outcomes are
binary the definition of a measure of association is tricky and requires to account for
several critical aspects. The dependence structure characterizing categorical variables
is usually hard to investigate because pairwise associations do not provide a complete
picture of it, but higher order associations need to be considered. Also, exploring the
parameter space, which consists of joint probabilities, is awkward especially because
its dimension increases exponentially as the number of variables increases.
The main contribution of the paper consists in providing a novel and appealing
framework for drawing causal inference for binary multivariate outcomes. Specifically,
we discuss and address the following issues. First, we formally define causal effects on
multiple binary outcomes adopting the potential outcome approach to causal infer-
ence, commonly referred to as Rubin’s Causal Model (RCM, e.g., Rubin, 1974, 1977,
1978). See also Imbens and Rubin (2015) for a comprehensive overview of the poten-
tial outcome approach. Specifically, we focus on causal relative risks, that is, ratio of
probabilities of success corresponding to potential outcomes under different treatment
conditions on a common set of units. Second, to formally define the causal estimands
of interest, we introduce new binary outcomes, defined as function (product) of sub-
sets of outcomes, that we call product outcomes. We propose a decomposition of
the causal relative risks for product outcomes into two components: one representing
causal effects on marginal outcomes, and the other representing causal effects on the
outcomes’ dependence structure. This decomposition may provide valuable informa-
tion on how the treatment acts, revealing whether treatment effects on the multi-
variate outcome are mainly either through treatment effects on (subsets of) marginal
outcomes or through treatment effects on the outcomes’ dependence structure. Third,
we propose to model the joint distribution of potential outcomes (conditional on a
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set of pre-treatment variables) using the class of log-mean linear regression models
introduced by Lupparelli and Roverato (2017). We generalize and extend results in
Lupparelli and Roverato (2017) in order to properly account for the fact that here
models are specified for the potential outcomes, rather than observed outcomes. We
show that the model parameters are directly interpretable in term of the causal rela-
tive risks we are interested in and that they can be combined to derive a natural and
easily interpretable decomposition of the causal relative risks for product outcomes.
We illustrate our framework in two medical examples, to which we refer as the
morphine study and the honey study throughout the paper. The morphine study is
a prospective, randomized, double-blind clinical study aimed at evaluating the effect
of preoperative administration of oral morphine sulphate on postoperative pain relief
(see Borracci et al., 2013, for details). We use this study to illustrate the key concepts
throughout the paper.
The honey study is a clinical randomized experiment aimed at evaluating the
effect of buckwheat honey or honey-flavored dextromethorphan (an over-the-counter
drug) versus no treatment on nocturnal cough and sleep difficulties associated with
childhood upper respiratory tract infections (Paul et al., 2007).
2 Theoretical Framework
2.1 Basic setup
Given a finite set V = {1, . . . , p}, let YV = (Yv)v∈V be the vector of binary outcomes
of interest. Every single outcome takes level 1 in case of success, and level 0 in case of
failure; then, the full vector YV takes value yV ∈ IV = {0, 1}
|V |, where |V | = p is the
cardinality of the set V . For every D ⊆ V , YD is a marginal vector of outcomes such
that YD = 1D, if Yv = 1 for all v ∈ D, YD = 0D, if Yv = 0 for all v ∈ D, and it takes
any other value yD ∈ ID = {0, 1}
|D|, with yD 6= 1D, 0D, otherwise; where 1D and 0D
are two vectors of 1s and 0s of size |D|. For every multiple outcome YD = (Yv)v∈D
with D ⊆ V , we refer to the event YD = 1D as a joint success, and to the event defined
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by any other level yD 6= 1D as a joint failure. Notice that, among the joint failure
events, we do not distinguish between YD = 0D and YD = yD for any yD 6= 1D, 0D,
because both cases do not represent the event of interest, that is, a joint success.
In this work we are interested in assessing effects of a treatment both on single
variables, Yv, v ∈ V , as well as on joint variables YD with D ⊆ V and |D| > 1.
Specifically, we are interested in assessing treatment effects on the occurrence of a
joint success YD = 1D, for every D ⊆ V . To this aim we make use of a new set of
variables that we call D-product outcomes.
Given a random vector YV = (Yv)v∈V of binary outcomes, for every non-empty
subset D of V , the D-product outcome is defined as follows:
Y D =
∏
v∈D
Yv. (2.1)
Let V be the power set of V minus the empty-set and let Y V = (Y D)D⊆V,D 6=∅
denote the vector of all product outcomes. For sake of simplicity, in the sequel we
adopt the shorthand notation D ⊆∅ V and D ⊂∅ V to denote any subset (or proper
subset) D of V not equal to the empty-set. For any pair Y D and Y D
′
with D′ ⊂∅ D,
we say that Y D
′
is a nested product outcome of Y D. Note that each Y D is a binary
variable which takes level 1 if YD = 1D, and level 0 otherwise, that is, Y
D = 1 if
and only if a joint success realizes for the outcome variable YD. Assessing treatment
effects on D-product outcomes, Y D ∈ Y V , represents the main focus of our work. See
also Lupparelli and Roverato (2017) who adopt similar product variables for different
purposes.
It is straightforward to figure out that, in case of non-independent outcomes,
effects of the treatment on Y D cannot be investigated by only exploiting informa-
tion about treatment effects on single outcomes: the treatment may affect Y D both
through its effect on each single outcome, Yv, v ∈ D, as well as through its effect on
the association structure among the variables belonging to YD. In order to formal-
ize these concepts we need to define causal effects introducing a formal framework
for causal inference. We adopt the potential outcome approach to causal inference
(Rubin, 1974, 1977, 1978).
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2.2 Potential Outcomes
Consider a group of units each of which can potentially be assigned to a binary
treatment w, with w = 1 for active treatment and w = 0 for control. We take a
super-population perspective, considering the n observed units as a random sample
from an infinite super-population. Under the stable unit treatment value assumption
(SUTVA, Rubin, 1980), which rules out both hidden versions of treatments as well as
interference between units, we can define for each outcome variable, Yv, v ∈ V , two
potential outcomes for each unit. Let Yv(0) denote the value of Yv under treatment
w = 0, and let Yv(1) denote the value of Yv under treatment w = 1. Let YV (w) =
(Yv(w))v∈V be the random vector including potential outcomes for every variable
under treatment level w, w = 0, 1. Potential outcomes for D product outcomes need
to be introduced, too. Let Y V(w) = (Y D(w))D⊆∅V be the random vector ofD-product
potential outcomes where, for every non-empty subset D of V ,
Y D(w) =
∏
v∈D
Yv(w). (2.2)
Every Y D(w) is a binary random variable which takes level 1 if YD(w) = 1D,
and level 0 otherwise. For the special case with |D| = 1, the D-product potential
outcome Y D(w) coincides with a potential outcome Yv(w), for a certain v ∈ V . Then
Y V(w) = (Y D(w))D⊆∅V is the augmented vector combining the vector YV (w) with all
the D-product potential outcomes Y D(w) for any D ⊆∅ V .
Example 2.1. Morphine study. Let YV (w) = (Y1(w), Y2(w)) be a bivariate vector,
with Y1(w) and Y2(w) denoting pain intensity after surgery at rest and on move-
ment, respectively (0 = high; 1 = low) under treatment level w, with w = 0 for the
placebo treatment and w = 1 for the preoperative morphine treatment. Then, we have
Y V(w) = (Y1(w), Y2(w), Y
{1,2}(w)), where Y {1,2}(w) = Y1(w) · Y2(w) is a binary vari-
able equal to one for patients with a low level of pain intensity both at rest and on
movement under treatment level w.
In our analysis we assume that a set of individual covariates is also available, which
are collected in a vector XU with U = {1, . . . , q} defining the finite set of indexes for
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the covariates. In this context, without loss of generality, we consider binary covariates
such that XU = xU , with xU ∈ IU = {0, 1}
q. Nevertheless the generalization for the
inclusion of continuous covariates is conceptually straightforward.
3 Causal estimads
3.1 Causal relative risks
In the potential outcome approach, causal effects are defined as comparisons of poten-
tial outcomes under different treatment levels for a common set of units. For instance,
a causal effect of the treatment w = 1 versus treatment w = 0 on a single outcome Yv
is defined as a comparison of the potential outcomes Yv(1) and Yv(0) on a common
set of units.
In this paper we focus on causal relative risks. The causal relative risk for a
specific outcome Yv is defined as follows:
RRv =
P [Yv(1) = 1]
P [Yv(0) = 1]
, v ∈ V. (3.1)
Sometimes the interest is on casual effects for specific sub-populations defined in
terms of a set XU of covariates, that is, on conditional causal effects (e.g., Imbens,
2004; Imbens and Athey, 2015). For example, we may be interested in the causal
relative risk of the morphine treatment on post-operative pain intensity on movement
for male and female, separately. Then, the relative risk of the treatment on an
outcome, Yv, given a fixed level xU of the covariates, is
RRv|xU =
P [Yv(1) = 1 | XU = xU ]
P [Yv(0) = 1 | XU = xU ]
, v ∈ V, xU ∈ IU . (3.2)
Throughout the paper, we will focus on the causal relative risks in Equation (3.2)
and we define new causal estimands conditional on values xU ∈ IU of the covariate
set XU , because they may provide precious information on the effectiveness of the
treatment across sub-populations defined by the values of the covariates. Nevertheless
marginal effects can be derived marginalizing over XU .
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For any product outcome Y D, let
RRD|xU =
P [Y D(1) = 1 | XU = xU ]
P [Y D(0) = 1 | XU = xU ]
, D ⊆ V, xU ∈ IU . (3.3)
be the D-product relative risk for a given value, xU , of a set XU of covariates.
In the special case when |D| = 1, Equation (3.3) coincides with Equation (3.2).
Also, we adopt the convention RR∅|xU = 1, so that, when D is used to index the
relative risk RRD|xU rather than a product outcome Y
D, we can avoid to specify
D 6= ∅.
3.2 Marginal and joint causal effects
For any product outcome Y D ∈ Y V , we propose to distinguish between two different
causal effects that we call the marginal effect and the joint effect of the treatment.
The former accounts for the effect deriving from the product-structure of Y D, which
necessarily embodies information provided by causal effects on marginal product out-
comes Y D
′
, for all D′ ⊂∅ D. The latter accounts for the effect of the treatment on
the association structure of the joint distribution of YD.
It is reasonable to expect that causal effects in Equation (3.3) are a combination of
marginal and joint effects. For instance, the effect of the morphine treatment on post-
operative pain intensity at rest and on movement, Y {1,2}, combines the marginal effect
of the treatment on each single outcome with the joint effect on their association.
In order to formally address these concepts, we introduce two additional causal es-
timands. Given any causal estimand θD|xU for the product-outcome Y
D, the marginal
causal effect (MCE) is defined as
MCED|xU = h[(θD′|xU )D′⊂D], D ⊆ V, (3.4)
for a suitable function h : R2
|D|−1 → R. The joint causal effect (JCE) is defined as
comparison of an association measure g(·) between the joint distributions of YD(1)
and YD(0):
JCED|xU : (3.5)
g[P (YD(1) | XU = xU )] versus g[P (YD(0) | XU = xU)], D ⊆ V.
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Investigating these two causal effects represents an interesting issue, because they
may provide useful insights on how the treatment acts. To fix the ideas, suppose
that for any vector YD(w), D ⊆ V , w = 0, 1, the components Yv(w), with v ∈ D
are mutual independent given the covariates. Then, the causal relative risk for every
D ⊆ V is
RRD|xU =
P [Y D(1) = 1 | XU = xU ]
P [Y D(0) = 1 | XU = xU ]
=
P [∩v∈DYv(1) = 1 | XU = xU ]
P [∩v∈DYv(0) = 1 | XU = xU ]
=
∏
v∈D P [Yv(1) = 1 | XU = xU ]∏
v∈D P [Yv(0) = 1 | XU = xU ]
=
∏
v∈D
P [Yv(1) = 1 | XU = xU ]
P [Yv(0) = 1 | XU = xU ]
=
∏
v∈D
RRv|xU ,
that is, the D-product relative risk RRD|xU is function of the causal relative risks
RRv|xU for single nested outcomes, for any v ∈ D and D ⊆ V . This represents an
extreme case where g[P (YD(1) | XU = xU)] = g[P (YD(0) | XU = xU)] because of
independence. In this case there is no joint effect and the causal effect is totally given
by the marginal effect.
3.3 Observed and Missing Potential Outcomes
Unfortunately, we cannot directly observe both YV (0) and YV (1) for any subject. After
the treatment has taken on a specific level, only the potential outcomes corresponding
to that level are realized and can be actually observed. Formally, let W denote the
actual treatment assignment: W = 0 for units assigned to the control group, and
W = 1 for units assigned to the treatment group. We observe Y obsV ≡ YV (W ) =
W · YV (1) + (1 − W ) · YV (0), but the other potential outcomes, Y
mis
V ≡ YV (1 −
W ) = (1−W ) · YV (1)+W · YV (0), are missing. Therefore, causal inference problems
under the potential outcome approach are inherently missing data problems, and some
assumption on the treatment assignment mechanism is required to draw inference on
causal effects.
In what follows, we will maintain the following assumption:
Assumption 1. Random treatment assignment:
P (W | YV (0), YV (1), XU) = P (W )
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Random assignment of the treatment, which usually holds by design in randomized
experiments, can be easily relaxed assuming that treatment assignment is independent
of potential outcomes conditional on the observed covariates: P (W | YV (0), YV (1), XU) =
P (W | XU).
Assumption 1 guarantees that the comparison of treated and control units leads to
valid inference on causal effects. In this paper we propose a model-based approach to
causal inference deriving maximum likelihood estimators of the causal parameters of
interest. Henceforth, we assume that YV (0) and YV (1) are independent, conditional on
the covariates. This assumption has little inferential effect for causal estimands that
do not depend on the association between individual potential outcomes as the super-
population causal effects we focus on (see, e.g., Imbens and Rubin, 2015, Chapter 8,
for further details).
4 A Regression model for multiple binary poten-
tial outcomes
4.1 A multivariate model for multiple potential outcomes
We assume that the random vector YV (w) | {XU = xU} with xU ∈ IU for w =
0, 1, follows a multivariate Bernoulli distribution with probability parameter vector
piV |xU (w) = (piD|xU (w))D⊆V . The generic element piD|xU (w), w = 0, 1, is the following
joint probability:
piD|xU (w) = P (YD(w) = 1D, YV \D(w) = 0V \D | XU = xU), D ⊆ V, xU ∈ IU .
Let µV |xU (w) = (µD|xU (w))D⊆V be the mean parameter, where the generic element,
µD|xU (w), is the marginal probability of the event YD(w) = 1D given the covariate set
XU = xU :
µD|xU (w) = P (YD(w) = 1D | XU = xU ), D ⊆ V, xU ∈ IU ,
with µ∅|xU (w) = 1, w = 0, 1. It follows that the conditional distribution of a D-
product potential outcome, Y D(w) | {XU = xU}, is an univariate Bernoulli random
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variable with probability parameter µD|xU (w), D ⊆ V and w = 0, 1. Then, the causal
relative risks in Equation (3.3) can be also written as function of the mean parameters,
for any xU ∈ IU :
RRD|xU =
µD|xU (w = 1)
µD|xU (w = 0)
, D ⊆ V. (4.1)
We now introduce the log-mean linear parameterization developed by Roverato et al.
(2013), which is the core of the regression framework we use for modeling multiple
binary non-independent potential outcomes.
Given the probability distribution of a random vector YV (w) | {XU = xU} with
mean parameter µV |xU (w), w = 0, 1, let γV |xU (w) = (γD|xU (w))D⊆V be the log-mean
linear parameter vector with
γD|xU (w) =
∑
D′⊆D
(−1)|D\D
′| logµD′|xU (w), D ⊆ V, xU ∈ IU . (4.2)
The term γD|xU (w), to which we refer as log-mean linear interaction, represents
a measure of association in the joint distribution of YD(w) | {XU = xU}, for any
D ⊆ V .
4.2 Log-mean linear regression models
Lupparelli and Roverato (2017) show that using the log-mean linear parameteriza-
tion as link function for categorical response variables, the class of log-mean linear
regression models results. We extend this approach for modeling the joint distribu-
tion of potential outcomes conditional on covariates, YV (w) | {XU = xU}, w = 0, 1
and xU ∈ IU . Of course alternative model specifications can be considered, but we
consider this method appealing because the model parameters directly provide infor-
mation on the causal estimands introduced in Section 3. Moreover the decomposition
into marginal and joint effect can be easily expressed as function of model parameters.
Formally, the two saturated log-mean linear regression models for the conditional
distribution of each potential outcome YV (w) | XU for w = 0, 1 are given by
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γD|xU (w = 0) = αD +
∑
E⊆U
αD|E, D ⊆ V
γD|xU (w = 1) = αD + αD(w = 1) +
∑
E⊆U
αD|E +
∑
E⊆U
αD|E(w = 1), D ⊆ V.
(4.3)
The causal effect of the treatment on the log-mean linear interaction can be defined
as
γD|xU (w = 1)− γD|xU (w = 0) = αD(w = 1) +
∑
E⊆U
αD|E(w = 1), D ⊆ V. (4.4)
In particular, the parameter αD(w = 1) corresponds to the causal effect on the log-
mean linear interaction given the baseline level xU = 0, and the parameters αD|E(w =
1) represent the treatment effect heterogeneity for different covariate configurations,
with E ⊆ U . For instance, the causal effect on the log-mean linear interaction for
xE = (1E , 0U\E) ∈ IU is
γD|xE(w = 1)− γD|xE(w = 0) = (4.5)
αD(w = 1) +
∑
E′⊆E
αD|E′(w = 1), E ⊆ U, D ⊆ V.
As far as the remaining parameters are concerned, αD represents the intercept
and αD|E corresponds to the effect of covariates XE on the log-mean linear interaction
given XU\E = 0U\E, for any E ⊆ U and D ⊆ V .
The following lemma and theorem show that we can derive the causal relative
risk on each product outcome Y D, D ⊆∅ V , defined in Equation (3.3), by combining
causal effects on log-mean linear interactions in Equation (4.4).
Lemma 4.1. Under the log-mean linear regression models in Equation (4.3), for the
baseline level xU = 0 of the covariate set XU , we have
αD(w = 1) =
∑
D′⊆D
(−1)|D\D
′| logRRD′|xU=0, D ⊆ V. (4.6)
The following theorem shows how causal relative risks are given combining model
parameters.
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Theorem 4.1. Under the log-mean linear regression models in Equation (4.3), for
any product outcome Y D, the causal relative risk given the baseline level xU = 0 of
the covariate set XU is
RRD|xU=0 = exp
{∑
D′⊆D
αD′(w = 1)
}
, D ⊆ V. (4.7)
In the sequel, Equation (4.7) is often written as RRD|xU=0 =
∏
D′⊆D exp{ αD′(w =
1)}, D ⊆ V . For the special case with |D| = 1, the causal effect for a single outcome
given the baseline level of the covariates is RRD|xU=0 = exp{αD(w = 1)}.
The following corollary formally shows that the causal relative risk for any sub-
population defined by any covariate configuration xU ∈ IU is function of the log-mean
linear regression coefficients.
Corollary 4.1. The relative risk of a product outcome Y D for any value xU ∈ IU is
RRD|xU =
∏
D′⊆D
exp
{
αD′(w=1) +
∑
E⊆U
αD′|E(w=1)
}
, D ⊆ V. (4.8)
Note that, if αD|E(w = 1) = 0, D ⊆ V and E ⊆ U , then causal effects for Y
D are
homogeneous, that is, the relative risks for sub-populations defined by any xU ∈ IU
are all equals to the relative risk in Equation (4.7).
Example 4.1. In the morphine study with YV (w) = (Y1(w), Y2(w)), we observe two
covariates: gender and age. We can dichotomize the variable age and construct a
vector XU = (X3, X4) of two binary covariates, gender and age. The log-mean linear
regression model for YV (0) | XU is given by the following three equations
γ1|34(w = 0) = α1 + α1|3 + α1|4 + α1|34
γ2|34(w = 0) = α2 + α2|3 + α2|4 + α2|34
γ12|34(w = 0) = α12 + α12|3 + α12|4 + α12|34
and the log-mean linear regression model for YV (1) | XU is given by the following three
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equations:
γ1|34(w = 1) = α1 + α1(w = 1) + α1|3 + α1|4 + α1|34 +
α1|3(w = 1) + α1|4(w = 1) + α1|34(w = 1)
γ2|34(w = 1) = α2 + α2(w = 1) + α2|3 + α2|4 + α2|34 +
α2|3(w = 1) + α2|4(w = 1) + α2|34(w = 1)
γ12|34(w = 1) = α12 + α12(w = 1) + α12|3 + α12|4 + α12|34+
α12|3(w = 1) + α12|4(w = 1) + α12|34(w = 1)
The parameters α1(w = 1) and α2(w = 1) are related to the causal relative risks given
the covariates’ baseline level for Y1 and Y2, respectively. Specifically RR1|xU=0 =
exp{α1(w = 1)} and RR2|xU=0 = exp{α2(w = 1)}. Consider now the parameter
α12(w = 1). We have
α12(w = 1) =
∑
D′⊆D
(−1)|D\D
′| logRRD′|xU=0
= logRR12|xU=0 − logRR1|xU=0 − logRR2|xU=0.
Therefore, RR12|xU=0 = exp{α1(w = 1) + α2(w = 1) + α12(w = 1)}.
In this simple example with two binary covariates, for each binary outcome Y1, Y2
and Y {1,2}, using Corollary 4.1, we can derive four causal relative risks, depending on
the value of the two binary covariates, X3 and X4. For instance, given xU = {x3 =
1, x4 = 0},
RR1|xU = exp
{
α1(w = 1) + α1|3(w = 1)
}
,
RR2|xU = exp
{
α2(w = 1) + α2|3(w = 1)
}
,
RR12|xU = exp
{
α12(w = 1) + α12|3(w = 1)
}
× RR1|xU × RR2|xU .
4.3 Marginal and joint causal effects using log-mean linear
parameters
We now show how the decomposition of the causal relative risk on a product outcome
into its marginal and joint components naturally follows with a straightforward inter-
pretation, using the log-mean linear regression model in Equation (4.3). In particular,
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we specify the functions in Equations (3.4) and (3.5) in terms of model parameters.
For simplicity, we focus on the baseline level of the covariates, xU = 0, but the follow-
ing reasoning applies to every level of the covariates xU ∈ IU . Then, for the baseline
level xU = 0 of the covariate set XU , respectively, as follows:
MCED|xU=0 =
∏
D′⊂D
exp{αD′(w = 1)}, D ⊆ V, (4.9)
JCED|xU=0 = exp{αD(w = 1)}, D ⊆ V. (4.10)
From Equation (4.4), we have that Equation (4.10) is function of the joint probability
of YD(w) | {XU = 0}, for w = 0, 1 in accordance with Equation (3.5); in particular,
from Lemma 4.1 we have that the adopted measure of association is g[P (YD(w) |
XU = 0)] =
∑
D′⊆D(−1)
|D\D′| logP [YD′(w) = 1 | XU = 0] for w = 0, 1, and that
JCED|xU=0 = g[P (YD(1) | XU = 0)]/g[P (YD(0) | XU = 0)], D ⊆ V. (4.11)
Therefore, JCED|xU=0 = 1 if there is no joint effect. The following lemma shows
that Equation (4.9) is function of the causal estimands we propose, that is, the causal
relative risks for nested outcomes, Y D
′
, with D′ ⊂∅ D, following the general definition
in Equation (3.4).
Lemma 4.2. Under the log-mean linear regression models in Equation (4.3), for any
Y D,
MCED|xU=0 =
[ ∏
D′⊂D
RR
(−1)|D\D
′|
D′|xU=0
]−1
, D ⊆ V. (4.12)
Equations (4.9) and (4.10) can be extended to every value of the covariate set XU .
Specifically, for every D ⊆ V and xU ∈ IU ,
MCED|xU =
∏
D′⊂D
exp
{
αD′(w = 1) +
∑
E⊆U
αD′|E(w = 1)
}
, (4.13)
JCED|xU = exp
{
αD(w = 1) +
∑
E⊆U
αD|E(w = 1)
}
. (4.14)
Lemma 4.2 can be also generalized for each value of the covariate set XU using
Corollary 4.1.
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The proposition below shows that for every product outcome Y D ∈ Y V , the
decomposition of the causal effect into its marginal and joint components naturally
follows.
Proposition 4.1. Under the log-mean linear regression models in Equation (4.3), for
any product outcome Y D,
RRD|xU = JCED|xU ×MCED|xU , D ⊆ V, (4.15)
given any xU ∈ IU of the covariate set XU .
The case |D| = 1 is trivial because JCED|xU = RR∅|xU = 1 and RRD|xU =
MCED|xU .
Corollary 4.2. Under the log-mean linear regression models in Equation (4.3), for
any product outcome Y D, and for any xU ∈ IU ,
RRD|xU =MCED|xU , D ⊆ V (4.16)
if and only if
αD(w = 1) +
∑
E⊆U
αD|E(w = 1) = 0, D ⊆ V (4.17)
A special case of Corollary 4.2, is for baseline level xU = 0 of the covariates, when
RRD|xU=0 =MCED|xU=0 if and only if αD(w = 1) = 0, for any D ⊆ V . The following
corollary shows that Corollary 4.2 necessary holds in case of independence.
Corollary 4.3. For any potential outcome YD(w) with D ⊆ V and w = 0, 1, suppose
that there exist a partition A and B of D with A,B 6= ∅ and A ∩ B = ∅ such that
YA(w) and YB(w) are independent given XU = xU , for any value xU ∈ IU of the
covariates XU . Then, under the log-mean linear regression model in Equation (4.3),
for any product outcome Y D, and for any xU ∈ IU ,
RRD|xU =MCED|xU , D ⊆ V. (4.18)
Following Corollary (4.3), we remark that independence is a sufficient but not
a necessary condition in order to have RRD|xU = MCED|xU , for any D ⊆ V and
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xU ∈ IU . In particular, Equation (4.16) holds whenever the treatment affects the
product outcome Y D, but has no effect on the association structure of the joint
distribution of YD, D ⊆ V . Then, it is possible that causal effects on marginal
outcomes contain all relevant information about the causal effects of the treatment,
and thus the association among outcomes can be neglected, even in case of non-
independent outcomes.
To be thorough, it is worth mentioning another, although less interesting, case,
too. If αD′(w = 1) = 0 for every D
′ ⊂ D, for a given D ⊆ V with |D| > 1, then
MCED|xU=0 = 1, and we get RRD|xU=0 = JCED|xU=0. Therefore, it could be possible
that the treatment has a casual effect on Y D, even if it has no effect on every nested
product outcome, Y D
′
, D′ ⊂ D. In this case, the casual effect on Y D would be totally
given by the effect of the treatment on the dependence structure of YD.
Example 4.2. Consider the scenario described in Example 4.1, where we have YV (w) =
(Y1(w), Y2(w)) and a vector XU = (X3, X4) of two binary covariates, and the log-mean
linear regression model for YV (w) | XU , w = 0, 1. Suppose we are interested in the
relative risk RR{1,2}|xU=0. This effect can be decomposed into the marginal causal ef-
fect and the joint causal effect, which can be written, using the log-mean linear model
coefficients, as follows:
MCE12|xU=0 = exp{α1(w = 1)} × exp{α2(w = 1)}
JCE12|xU=0 = exp{α12(w = 1)}.
Then,
RR12|xU=0 = exp{α(w = 1)} × exp{α2(w = 1)} × exp{α12(w = 1)}.
If the logarithm of the joint effect is null, i.e. α12(w = 1) = 0, then causal effects on
Y {1,2} are only through causal effects on each marginal outcome, Y1 and Y2. The same
result also holds for every level xU ∈ IU of the covariates. For instance, consider xU =
{x3 = 1, x4 = 0}, then MCE12|xU = exp{α1(w = 1) + α1|3(w = 1)} × exp{α2(w =
1) + α2|3(w = 1)} and JCE12|xU = exp{α12(w = 1) + α12|3(w = 1)}. In the log-mean
linear regression model, which involves hierarchical effects, α12(w = 1) = 0 implies
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that α12|E(w = 1) = 0 for any E ⊆ U , therefore if α12(w = 1) = 0 then JCE12|xU = 1
and RR12|xU =MCE12|xU .
4.4 Inference
For inference, we use a maximum likelihood approach. In particular, maximum like-
lihood estimators are obtained by implementing an algorithm inspired on the maxi-
mization procedure developed in Lang (1996), properly adjusted for working out the
estimates of the causal effects of interest and the corresponding standard errors. A
similar maximization procedure has been also discussed by Lupparelli (2006) in the
context of marginal models. For technical details and a review of further maximiza-
tion approaches see also Evans and Forcina (2013) and references therein.
5 Applications
5.1 The Morphine Study
The morphine study is a prospective, randomized, double-blind study concerning the
effect of preoperative oral administration of morphine sulphate on postoperative pain
relief. The study involved a random sample of n = 60 patients aged 18−80 who were
undergoing an elective open colorectal abdominal surgery. Out of these 60 patients,
32 were randomly assigned to the treatment group, and 28 were randomly assigned to
the control group. LetW denote the observed treatment variable. Before surgery, pa-
tients in the treatment group with W = 1, were administered oral morphine sulphate
(Oramorph R©, Molteni Farmaceutici, Italy), and patients in the control group with
W = 0, received oral midazolam (Hypnovel R©, Roche, Switzerland), a short-acting
drug inducing sedation, which is considered as an active placebo.
The outcome of primary interest is post-operative pain intensity measured using
visual analogue scale scores at rest and for movement (that is, upon coughing). Visual
analogue scale scores are measured using a line of 100 mm where the left extremity
is no pain and the right one is extreme pain. Here we focus on pain intensity at
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Table 1: Maximum likelihood estimates of the log-mean linear regression model for
{YS(w), YDy(w)} | {XA, XG} (in brackets the standard errors).
Y D(w) | XU αˆD αˆD(w = 1) αˆD|A αˆD|G
Y S(w) | XU -1.600 (0.343) 1.008 (0.325) 0.205 (0.209) 0.270 (0.195)
Y Dy(w) | XU -2.437 (0.560) 1.122 (0.498) 0.700 (0.439) 0.024 (0.330)
Y {S,Dy}(w) | XU 1.148 (0.399) -0.592 (0.381) -0.178 (0.204) -0.269 (0.194)
rest and for movement 4 hours after the end of surgery (see Borracci et al., 2013, for
further details on the study). Physicians consider a pain score not greater than 30
mm at rest, and not greater than 45 mm on movement as a satisfactory pain relief.
Therefore we dichotomize the two outcome variables using 30 and 45 as cutoff points
for pain intensity at rest and for movement, respectively. Let Y1 = YS and Y2 = YDy
denote the binary indicators for low versus high visual analogue scale scores at rest
and for movement, respectively.
Under SUTVA, let YS(w) and YDy(w) define the potential outcomes for pain in-
tensity at rest and for movement, respectively, given assignment to treatment level w:
YS(w) and YDy(w) are binary variables equal to 1 for patients with visual analogue
scale score at rest and for movement not greater that 30 mm and 45 mm, respectively,
given assignment w, and 0 otherwise. Let YS(W ) and YDy(W ) be the actual outcomes
observed. For each patient we also observe two covariates, gender, XG (XG = 0 for
females; and XG = 1 for males), and age in years. We dichotomize the variable age
considering a binary variable XA equal to 1 for patients older than 65 years, and 0
otherwise. So we get the vector XU = (XA, XG) of two binary covariates.
Let us consider the log-mean linear regression models for {YS(0), YDy(0)} | {XA, XG}
and {YS(1), YDy(1)} | {XA, XG} with no-interaction terms: αD|A,G = 0, and αD|E(w =
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1) = 0, for each D ⊆ {S,Dy} and E ∈ {A,G}:
γS|A,G(w = 0) = αS + αS|A + αS|G,
γDy|A,G(w = 0) = αDy + αDy|A + αDy|G,
γS,Dy|A,G(w = 0) = αS,Dy + αS,Dy|A + αS,Dy|G
and
γS|A,G(w = 1) = αS + αS(w = 1) + αS|A + αS|G,
γDy|A,G(w = 1) = αDy + αDy(w = 1) + αDy|A + αDy|G,
γS,Dy|A,G(w = 1) = αS,Dy + αS,Dy(w = 1) + αS,Dy|A + αS,Dy|G
This model specification implies that treatment effects are homogeneous across sub-
populations defined by the values of the two covariates. Therefore, in the following,
we do not need to specify the conditioning set, e.g. xU = 0, for any causal estimand.
The model has 12 degrees of freedom and gives a good fitting with deviance 11.753
(p-value= 0.466), and BIC = 332.807. The estimates in Table 1 show a positive
causal effect of treatment for both single outcomes. However, the joint causal effect
is not statistically significant, suggesting that the treatment has not effect on the
dependence structure between pain intensity at rest and on movement. The effect
of the two covariates is not significant, too. Therefore we repeat the analysis setting
αD|A = αD|G = 0 for any D ⊆ {S,Dy} and with α{S,Dy}(w = 1) = 0. This model
has 19 degrees of freedom and gives a good fitting with deviance 18.775, p-value
= 0.471, and BIC = 311.168. Notice that the same model with α{S,Dy}(w = 1) 6=
0 still gives a not significant estimate for this parameter, i.e., αˆ{S,Dy}(w = 1) =
−0.617 (se = 0.399). The estimates collected in Table 2 still show a positive causal
effect of treatment on both single outcomes, i.e., RˆRS|xU = exp(0.987) = 2.683, and
RˆRDy|xU = exp(1.279) = 3.593. For the product outcome Y
{S,Dy}, the total causal
effect coincides with the marginal causal effect, because the logarithm of the joint
causal effect is assumed to be null: log(JCE{S,Dy}|xU ) = 0, and thus RˆR{S,Dy}|xU =
ˆMCE{S,Dy}|xU = 2.683× 3.593 = 9.640.
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Table 2: Maximum likelihood estimates of the log-mean linear regression model for
{YS(w), YDy(w)} | {XA, XG} with zero constraints denoted by - (in brackets the
standard errors).
Y D(w) | XU αˆD αˆD(w = 1) αˆD|A αˆD|G
Y S(w) | XU -1.310 (0.297) 0.987 (0.313) - -
Y Dy(w) | XU -2.054 (0.459) 1.279 (0.494) - -
Y {S,Dy}(w) | XU 0.302 (0.386) - - -
5.2 The Honey data study
We consider a double-blinded randomized study taken by Paul et al. (2007), where
the focus is on evaluating the effects of a single nocturnal dose of buckwheat honey
or honey-flavored dextromethorphan versus no treatment on nocturnal cough and
sleep difficulty associated with childhood upper respiratory tract infections. A sam-
ple of patients aged between 2 and 18 years with cough attributes characterized by
the presence of rhinorrhea and cough for 7 or fewer days duration have been enrolled.
Subjective parental assessments about their child cough symptoms were assessed both
previous and after the treatment administration (see Paul et al., 2007, for details).
The primary outcomes of interest are cough bothersome (‘How bothersome was your
child’s coughing last night?’), cough frequency (‘How frequent was your child’s cough
last night?’) and cough severity (‘How severe was your child’s cough last night?’).
These outcomes are measured on a 7-point Likert scale from 0 (‘not at all’) to 6
(‘extremely’). Using univariate statistical techniques, Paul et al. (2007) found that
honey may be a preferable treatment. Significant differences in symptom improve-
ment were not detected between dextromethorphan and no treatment or between
dextromethorphan and honey for any outcome of interest.
We apply the model-based approach described in Section 4 for drawing inference
on the causal effect of honey on children respiratory infection due to considering
different combinations of three selected cough attributes: bothersome, frequency and
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Table 3: Maximum likelihood estimates of the log-mean linear regression model for
{YF (w), YS(w), YB(w)} | X (in brackets the standard errors).
Y D(w) | X αˆD αˆD(w = 1) αˆD|X
Y B(w) | X -1.050 (0.212) 0.599 (0.205) 0.289 (0.170)
Y F (w) | X -1.468 (0.265) 0.754 (0.240) 0.602 (0.209)
Y S(w) | X -1.386 (0.254) 0.532 (0.241) 0.601 (0.209)
Y {B,F}(w) | X 0.875 (0.201) -0.502 (0.192) -0.270 (0.155)
Y {B,S}(w) | X 0.953 (0.201) -0.517 (0.192) -0.341 (0.161)
Y {F,S}(w) | X 1.211 (0.235) -0.585 (0.211) -0.523 (0.195)
Y {B,F,S}(w) | X -0.792 (0.195) 0.423 (0.185) 0.269 (0.154)
severity. We dichotomize these variables merging levels 0 to 2 in level 1; and levels
3 to 6 in level 0. We focus on the sub-sample of 72 children receiving honey or no
treatment (ignoring children receiving dextromethorphan): 35 children were randomly
assigned to the honey treatment (W = 1) and 37 children were randomly assigned
to no treatment (W = 0). Then, under SUTVA, for each patient we get a vector
YV (w) = (YB(w), YF (w), YS(w)) of three potential outcomes given assignment w,
w = 0, 1. The variables YB(w), YF (w), and YS(w) respectively take value 1 in case
of absent or low bothersome, cough frequency and severity, and 0 otherwise. We are
also interested on the causal effect of honey on the product outcomes Y D included in
the augmented vector of Y V for every D ⊆ V . Each product outcome represents a
combinations of different cough symptoms, which may jointly occur to children, e.g.,
Y B,F (w) = 1 for children with absent or low cough bothersome and frequency under
treatment w, w = 0, 1.
We also consider an individual covariate X obtained combining pre-treatment
knowledge. Following Paul et al. (2007), we built up a variable by summing the
individual scores observed before the treatment about cough frequency, severity and
bothersome such that we get a pre-treatment discrete indicator ranging from 0 to 18,
which we dichotomize with respect to its (sample) median equal to 12. The resulting
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binary variable X takes on level 1 for values lower than the median and 0 otherwise.
We specified a log-mean linear regression model for YV (w) | X assuming no treat-
ment effect heterogeneity across sub-populations defined by the pre-treatment covari-
ate X : αD|X(w = 1) = 0, for each D ⊆ V . This model implies that causal effects are
homogeneous between children with a high pre-treatment health score and children
with a low pre-treatment health score.
The model shows a good fitting with 7 degree of freedom, deviance 10.093 and p-
value= 0.183. Parameter estimates are collected in Table 3 and estimates of the causal
effects are shown in Table 4. We get positive estimates of the honey causal effects
on each single outcome, but the strongest effect is on reducing the cough frequency.
Treatment has also a positive effect on product outcomes, improving conditions of
children suffering from combinations of different cough symptoms. In particular the
treatment appears to be more effective when the symptoms includes cough frequency.
All joint effects are statistically significant, suggesting that the treatment has an
effect on the association structure between the outcomes. The strongest joint effect
is found for the product outcome Y {B,F,S}, which combines critical cough frequency,
severity and bothersome. The causal relative risk on the product-potential outcomes
Y D with D ⊆ V are derived combining joint and marginal effects: for instance,
RˆR{B,F}|x = 0.606× 3.885 = 2.354.
Unlike the application on the morphine data, in this case we find strong evidence
that the analysis cannot be conducted separately on each single outcome because for
each product outcome Y D with D ⊆ V , the treatment effect on the association among
single outcomes Yv with v ∈ D cannot be ignored. Then, a multivariate approach is
definitively more suitable than an univariate one.
6 Conclusion
Causal inference in the presence of multiple non-independent outcomes represents a
challenging task for several reasons. In particular, an augmented set of outcomes
needs to be considered because also the joint occurrence of combinations of outcomes
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Table 4: Honey Study: Estimates of the causal effects (in brackets the standard
errors)
Estimand Estimate Estimand Estimate
Causal Relative Risks
RRB|x 1.820 (0.372) RR{B,F}|x 2.341 (0.614)
RRF |x 2.125 (0.511) RR{B,S}|x 1.847 (0.475)
RRS|x 1.702 (0.410) RR{F,S}|x 2.015 (0.552)
RR{B,F,S}|x 2.022 (0.561)
Joint Causal Effects Marginal Causal Effects
JCE{B,F}|x 0.605 (0.116) MCE{B,F}|x 3.869 (1.584)
JCE{B,S}|x 0.596 (0.115) MCE{B,S}|x 3.099 (1.282)
JCE{F,S}|x 0.557 (0.118) MCE{F,S}|x 3.618 (1.630)
JCE{B,F,S}|x 1.527 (0.283) MCE{B,F,S}|x 1.324 (0.326)
becomes of interest. These “new quantities” need to be formalized together with an
enlarged set of causal estimands, including the effect of treatment on combinations of
outcomes. We formalize these concepts for binary outcome variables by introducing
the notion of product outcomes and by decomposing the treatment effect on these
outcomes into the joint and marginal causal effects. A general definition for the
marginal and the joint causal estimands has been introduced, although their spec-
ification necessarily requires to make some decisions, for instance, by introducing
modeling assumptions.
We propose to model the joint distribution of potential outcomes using the class
of log-mean linear regression models proposed by Lupparelli and Roverato (2017).
Interestingly, the parameters of the resulting model are directly related to the causal
estimands of interest, and the analytic decomposition into marginal and joint effect
naturally arises.
24
Further approaches for multiple binary responses may be also explored, such as
the multivariate logistic regression of Glonek and McCullagh (1995). Nevertheless,
we deem that the class of log-mean linear regressions is particularly appealing when
the causal estimand of interest are causal relative risks.
A Appendix: Proofs
Proof of Lemma 4.1. Let us consider the causal effect in Equation (4.4) for the base-
line level xU = 0 of the covariates. For any D ⊆ V ,
αD(w = 1) = γD|xU=0(w = 1)− γD|xU=0(w = 0).
Then, from Equation (??) we have that, for any D ⊆ V ,
αD(w = 1) =
∑
D′⊆D
(−1)|D\D
′| log µD′|xU=0(1)−
∑
D′⊆D
(−1)|D\D
′| logµD′|xU=0(0).
It follows that
αD(w = 1) =
∑
D′⊆D
(−1)|D\D
′| logRRD′|xU=0, D ⊆ V
because logRRD′|xU=0 = log µD′|xU=0(1)− log µD′|xU=0(0).
Proof of Theorem 4.1. First of all we remark that, given any set D, the power set
P(D) = {D′} includes the same number 2|D|−1 of even and odd subsets, i.e.,
∑
D′⊆D(−1)
|D\D′| =
0.
From Lemma 4.1 we have that
∑
D′⊆D
αD′(w = 1) =
∑
D′⊆D


∑
D˜⊆D′
(−1)|D
′\D˜| logRRD˜|xU=0

 , D ⊆ V. (A.1)
Equation (A.1) is equivalent to
logRRD|xU=0 +
∑
D′⊆D


∑
D˜⊆D′:D˜ 6=D
(−1)|D
′\D˜| logRRD˜|xU=0

 , D ⊆ V. (A.2)
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The second addend in Equation (A.2) is null if for every D˜ ⊂ D, among all supersets
D′ ⊆ D such that D′ ⊇ D˜, there is the same number of even and odd subsets D′ \ D˜.
Notice that the case D˜ = ∅ is trivial because logRR∅|xU=0 = 0 by definition.
Now consider any non-empty subset D˜ ⊂ D. This is included in all supersets
D′ ⊆ D of type D′ = D˜ ∪K for any K ∈ P(D′ \ D˜) which is a power set having the
same number of even and odd subsets. Then, the result follows because
∑
D′⊆D


∑
D˜⊆D′:D˜ 6=D
(−1)|D
′\D˜| logRRD˜|xU=0

 = 0, D ⊆ V. (A.3)
Proof of Corollary 4.1. From Equation (??) we have
αD′(w = 1) +
∑
E⊆U
αD′|E(w = 1) = γD′|xU (w = 1)− γD′|xU (w = 0), D
′ ⊆ D, (A.4)
for every D ⊆ V and xU ∈ IU . From Equation (??), Equation (A.4) is equal to
∑
D˜⊆D′
(−1)|D
′\D˜| logµD˜|xU (w = 1)−
∑
D˜⊆D′
(−1)|D
′\D˜| log µD˜|xU (w = 0) (A.5)
which, by Equation (??), is also equal to
∑
D˜⊆D′(−1)
|D′\D˜| logRRD˜|xU , for any xU ∈
IU . Therefore, we have
∑
D′⊆D
{
αD′(w=1) +
∑
E⊆U
αD′|E(w=1)
}
= (A.6)
∑
D′⊆D


∑
D˜⊆D′
(−1)|D
′\D˜| logRRD˜|xU

 , D ⊆ V,
for any xU ∈ IU . The result follows applying the proof of Theorem 4.1.
Proof of Lemma 4.2. From Equation (4.6) and (4.7) we have, respectively,
αD(w = 1) = logRRD|xU=0 +
∑
D′⊂D
(−1)|D\D
′| logRRD′|xU=0
and
logRRD|xU=0 = αD(w = 1) +
∑
D′⊂D
αD′(w = 1),
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for any D ⊆ V . Then, the result follows given that, for any D ⊆ V ,
∑
D′⊂D
αD′(w = 1) = −
∑
D′⊂D
(−1)|D\D
′|RRD′|xU=0.
Proof of Proposition 4.1. For every D ⊆ V and any xU ∈ IU , the result follows by
applying Corollary 4.1 to the product of JCED|xU and MCED|xU , as respectively
defined in Equations (4.13) and (4.14).
Proof of Corollary 4.2. Suppose that Equation (4.16) holds. Then Proposition 4.1
implies that JCED|xU = 1 for any D ⊆ V , and thus Equation (??) holds given the
definition of JCED|xU in Equation (4.14). Vice versa, if Equation (4.17) holds, then
JCED|xU = 1 for any D ⊆ V , given the definition of JCED|xU in Equation (4.14).
Equation (4.16) follows from Proposition 4.1.
Proof of Corollary 4.3. Suppose that for each potential outcome YD(w) with D ⊆ V
and w = 0, 1, there exist a partition A and B of D ⊆ V such that YA(w) and
YB(w), are conditionally independent given XU = xU , xU ∈ IU . Then, we have
that γD|xU (0) = γD|xU (1) = 0 for Theorem 1 in Roverato et al. (2013). Then the
result follows because, under the log-mean linear regression model in Equation (4.3),
condition in Equation (4.17) is verified.
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